196 related articles for article (PubMed ID: 9876236)
1. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-I.
Burgess W; Liu Q; Zhou J; Tang Q; Ozawa A; VanHoy R; Arkins S; Dantzer R; Kelley KW
Neuroimmunomodulation; 1999; 6(1-2):56-68. PubMed ID: 9876236
[TBL] [Abstract][Full Text] [Related]
2. Control of the thymic microenvironment by growth hormone/insulin-like growth factor-I-mediated circuits.
Savino W; de Mello-Coelho V; Dardenne M
Neuroimmunomodulation; 1995; 2(6):313-8. PubMed ID: 8840333
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, growth factors and hematopoiesis.
Kelley KW; Arkins S; Minshall C; Liu Q; Dantzer R
Horm Res; 1996; 45(1-2):38-45. PubMed ID: 8742117
[TBL] [Abstract][Full Text] [Related]
4. Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging.
Kelley KW; Meier WA; Minshall C; Schacher DH; Liu Q; VanHoy R; Burgess W; Dantzer R
Ann N Y Acad Sci; 1998 May; 840():518-24. PubMed ID: 9629278
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors.
Minshall C; Arkins S; Dantzer R; Freund GG; Kelley KW
J Immunol; 1999 Apr; 162(8):4542-9. PubMed ID: 10201993
[TBL] [Abstract][Full Text] [Related]
6. Role of prolactin and growth hormone on thymus physiology.
De Mello-Coelho V; Savino W; Postel-Vinay MC; Dardenne M
Dev Immunol; 1998; 6(3-4):317-23. PubMed ID: 9814605
[TBL] [Abstract][Full Text] [Related]
7. The thymus gland: a target organ for growth hormone.
Savino W; Postel-Vinay MC; Smaniotto S; Dardenne M
Scand J Immunol; 2002 May; 55(5):442-52. PubMed ID: 11975755
[TBL] [Abstract][Full Text] [Related]
8. Decreases in growth hormone receptor signal transduction contribute to the decline in insulin-like growth factor I gene expression with age.
Xu X; Bennett SA; Ingram RL; Sonntag WE
Endocrinology; 1995 Oct; 136(10):4551-7. PubMed ID: 7664676
[TBL] [Abstract][Full Text] [Related]
9. The proliferative and antiapoptotic actions of growth hormone and insulin-like growth factor-1 are mediated through distinct signaling pathways in the Pro-B Ba/F3 cell line.
Baixeras E; Jeay S; Kelly PA; Postel-Vinay MC
Endocrinology; 2001 Jul; 142(7):2968-77. PubMed ID: 11416018
[TBL] [Abstract][Full Text] [Related]
10. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
[TBL] [Abstract][Full Text] [Related]
12. Requirement for phosphatidylinositol 3'-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor.
Minshall C; Arkins S; Freund GG; Kelley KW
J Immunol; 1996 Feb; 156(3):939-47. PubMed ID: 8558020
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction through the IL-4 and insulin receptor families.
Wang LM; Keegan A; Frankel M; Paul WE; Pierce JH
Stem Cells; 1995 Jul; 13(4):360-8. PubMed ID: 7549895
[TBL] [Abstract][Full Text] [Related]
14. Activation of phosphatidylinositol 3'-kinase by insulin-like growth factor-I rescues promyeloid cells from apoptosis and permits their differentiation into granulocytes.
Liu Q; Schacher D; Hurth C; Freund GG; Dantzer R; Kelley KW
J Immunol; 1997 Jul; 159(2):829-37. PubMed ID: 9218601
[TBL] [Abstract][Full Text] [Related]
15. The haematopoietic effects of growth hormone and insulin-like growth factor-I.
Merchav S
J Pediatr Endocrinol Metab; 1998; 11(6):677-85. PubMed ID: 9829220
[TBL] [Abstract][Full Text] [Related]
16. Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation.
Kermani H; Goffinet L; Mottet M; Bodart G; Morrhaye G; Dardenne O; Renard C; Overbergh L; Baron F; Beguin Y; Geenen V; Martens HJ
Neuroimmunomodulation; 2012; 19(3):137-47. PubMed ID: 22261974
[TBL] [Abstract][Full Text] [Related]
17. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
Koike M; Yamanaka Y; Inoue M; Tanaka H; Nishimura R; Seino Y
J Bone Miner Res; 2003 Nov; 18(11):2043-51. PubMed ID: 14606518
[TBL] [Abstract][Full Text] [Related]
19. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice.
Montecino-Rodriguez E; Clark R; Dorshkind K
Endocrinology; 1998 Oct; 139(10):4120-6. PubMed ID: 9751491
[TBL] [Abstract][Full Text] [Related]
20. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
